In this Breast Cancer Breakthroughs series, Harold Burstein, MD, PhD, speaks with breast cancer experts from Dana-Farber about new research presented at the 2026 ASCO Annual Meeting.

Topics include advances in early and metastatic breast cancer, new treatment approaches, clinical trial results, food access and poverty, weight loss and lifestyle, and emerging therapies such as antibody-drug conjugates and oral SERDs.

Listen to the full conversations to learn more about the latest research and what these findings could mean for breast cancer care.

Chapters:
00:00:00 Intro
00:01:31 SENOMAC trial - Laura S. Dominici, MD, FACS
00:09:55 Food Access, Poverty, and MBC - Rachel Freedman, MD, MPH
00:20:46 BWEL Trial - Jennifer A. Ligibel, MD
00:30:25 ASCENT-03/-04, and TROPION-Breast 02 Trials - Ana C. Garrido-Castro, MD
00:42:31 PANKU-Breast02 Trial - Ana C. Garrido-Castro, MD
00:49:46 HER2CLIMB-05 Trial - Adrienne Waks, MD
00:59:19 Neo-Healer Trial - Adrienne Waks, MD
01:09:28 persevERA Trial - Erica Mayer, MD, MPH
01:19:20 Outro

Resources mentioned in this episode:
Dana-Farber Food Pantry: https://www.dana-farber.org/patient-family/support-services/food-pantry

For more information about Dana-Farber’s Breast Oncology Center, visit https://www.dana-farber.org/cancer-care/treatment/breast-oncology

Follow us on social media:
Instagram: @danafarber_breast
Facebook: Dana-Farber Breast Oncology
X: @DFCI_BreastOnc

Disclaimer
This content is for informational and educational purposes only and is not intended as medical advice. Please consult a qualified healthcare professional for personalized medical guidance. The presented content reflects the views of the speakers and should not be interpreted as representing the views or policies of Dana-Farber Cancer Institute.